1. Immune-suppressive properties of the tumor microenvironment

   • Jürgen C. Becker
   • Mads Hald Andersen
   • Per thor Straten

   Review 11 May 2013 Pages: 1137 - 1148

   

2. Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide

   • Elise P. Salerno
   • Sofia M. Shea
   • Craig L. Slingluff Jr.

   Original Article 09 May 2013 Pages: 1149 - 1159

   

3. Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles

   • Rodney A. Rosalia
   • Ana Luisa Silva
   • Jaap Oostendorp

   Original Article 24 April 2013 Pages: 1161 - 1173

   

4. Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects

   • Sung Yong Lee
   • Tae Heung Kang
   • T.-C. Wu

   Original Article 25 April 2013 Pages: 1175 - 1185

   

5. Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy

   • Henry M. Smilowitz
   • Daniel Sasso
   • F. Avraham Dilmanian

   Original Article 25 April 2013 Pages: 1187 - 1197

   

6. Anti-metastatic potential of human Vδ1⁺ γδ T cells in an orthotopic mouse xenograft model of colon carcinoma

   • Christel Devaud
   • Benoît Rousseau
   • Myriam Capone

   Original Article 26 April 2013 Pages: 1199 - 1210

   

7. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors

   • Frank Neumann
   • Dominic Kaddu-Mulindwa
   • Boris Kubuschok

   Original Article 26 April 2013 Pages: 1211 - 1222

   

8. Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)

   • Antonia Busse
   • Jérôme Rapion
   • Ulrich Keilholz

   Original Article 27 April 2013 Pages: 1223 - 1233

   

9. Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity

   • Jens H. W. Pahl
   • S. Eriaty N. Ruslan
   • Marco W. Schilham

   Original Article 27 April 2013 Pages: 1235 - 1247

   

10. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions

    • Amedeo Amedei
    • Elena Niccolai
    • Mario Milco D’Elios

    Original Article 03 May 2013 Pages: 1249 - 1260

    

11. A novel recombinant protein of IP10-EGFRvIIIscFv and CD8⁺ cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice

    • Xuan Wang
    • Xiao-Ling Lu
    • Xiao-Bing Jiang

    Original Article 03 May 2013 Pages: 1261 - 1272

    

12. Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells

    • Karen C. Galvin
    • Lydia Dyck
    • Kingston H. G. Mills

    Original Article 09 May 2013 Pages: 1273 - 1282